PATENT CLAIM ANALYSIS

Application Number: 16140608
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "300000"]

Abstract:
The present invention relates to a pharmaceutical composition and a lyophilisate of a diazabicyclooctane derivative represented by Compound I, a process for producing the same and methods for using the same.

Claim (Index 19):
The method according to  claim 16  for treating a bacterial infection in a subject in need thereof comprising administering to the subject the pharmaceutical composition in amount sufficient to inhibit a bacterial \u03b2-lactamase.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14251372', '14856075', '15844961', '16061868', '14285185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.715525880458349
- 35 USC 102 Novelty (BERT): 0.500530791729121
- Combined Prediction Score: 0.6940263715854262
- Mean Citation Score: 187.177368
- Max Citation Score: 204.21404
- Similarity Product: 126.85782763054848

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test